Efficacy and Safety of Bushenjiangya-Optimized Granule for Left Ventricular Diastolic Dysfunction in Hypertensive Patients: A Double-Blind, Randomized, Placebo-Controlled Trial.
Qun GaoXiao-Yun CuiFei DongWen-Ying FanPin-Hui LiJing LiuJin-Jin LuYan MengWen-Bai QuKun ZhouQian LinPublished in: Evidence-based complementary and alternative medicine : eCAM (2020)
BSJYO granule plus basal WM is an effective and safe therapy for HTN patients with LVDD.
Keyphrases
- hypertensive patients
- left ventricular
- double blind
- blood pressure
- placebo controlled
- clinical trial
- hypertrophic cardiomyopathy
- phase iii
- heart failure
- open label
- acute myocardial infarction
- cardiac resynchronization therapy
- aortic stenosis
- phase ii
- mitral valve
- oxidative stress
- left atrial
- study protocol
- ejection fraction